Smith & Nephew plc (NYSE: SNN) Stock Competitors & Peer Comparison
See SNN's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for SNN and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SNN | $31.15 | -2.69% | 13.1B | 21.03 | $1.48 | +2.56% |
| ABT | $109.93 | -3.23% | 190.3B | 21.10 | $5.21 | +2.28% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| MDT | $101.80 | -2.90% | 130.2B | 18.41 | $5.53 | +2.81% |
| SYK | $325.87 | -2.75% | 124.1B | 24.34 | $13.39 | +1.09% |
| BSX | $42.75 | -4.23% | 62B | 13.79 | $3.10 | N/A |
| EW | $102.14 | +1.31% | 58.9B | 37.82 | $2.70 | N/A |
| GEHC | $82.38 | -1.64% | 37.2B | 16.81 | $4.90 | +0.18% |
| PHG | $30.35 | -0.52% | 29.7B | 17.34 | $1.75 | +3.27% |
| DXCM | $79.41 | -5.98% | 29.6B | 31.14 | $2.55 | N/A |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
SNN vs ABT Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, ABT has a market cap of 190.3B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while ABT trades at $109.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas ABT's P/E ratio is 21.10. In terms of profitability, SNN's ROE is +0.12%, compared to ABT's ROE of +0.09%. Regarding short-term risk, SNN is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for SNN.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
SNN vs BSX-PA Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, SNN's ROE is +0.12%, compared to BSX-PA's ROE of +0.14%. Regarding short-term risk, SNN is less volatile compared to BSX-PA. This indicates lower risk in terms of short-term price fluctuations for SNN.Check BSX-PA's competition here
Medtronic Plc (NYSE: MDT)
SNN vs MDT Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, MDT has a market cap of 130.2B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while MDT trades at $101.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas MDT's P/E ratio is 18.41. In terms of profitability, SNN's ROE is +0.12%, compared to MDT's ROE of +0.11%. Regarding short-term risk, SNN is less volatile compared to MDT. This indicates lower risk in terms of short-term price fluctuations for SNN.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
SNN vs SYK Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, SYK has a market cap of 124.1B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while SYK trades at $325.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas SYK's P/E ratio is 24.34. In terms of profitability, SNN's ROE is +0.12%, compared to SYK's ROE of +0.16%. Regarding short-term risk, SNN is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for SNN.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
SNN vs BSX Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, BSX has a market cap of 62B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while BSX trades at $42.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas BSX's P/E ratio is 13.79. In terms of profitability, SNN's ROE is +0.12%, compared to BSX's ROE of +0.14%. Regarding short-term risk, SNN is less volatile compared to BSX. This indicates lower risk in terms of short-term price fluctuations for SNN.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
SNN vs EW Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, EW has a market cap of 58.9B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while EW trades at $102.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas EW's P/E ratio is 37.82. In terms of profitability, SNN's ROE is +0.12%, compared to EW's ROE of +0.10%. Regarding short-term risk, SNN is less volatile compared to EW. This indicates lower risk in terms of short-term price fluctuations for SNN.Check EW's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
SNN vs GEHC Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, GEHC has a market cap of 37.2B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while GEHC trades at $82.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas GEHC's P/E ratio is 16.81. In terms of profitability, SNN's ROE is +0.12%, compared to GEHC's ROE of +0.16%. Regarding short-term risk, SNN is less volatile compared to GEHC. This indicates lower risk in terms of short-term price fluctuations for SNN.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
SNN vs PHG Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, PHG has a market cap of 29.7B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while PHG trades at $30.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas PHG's P/E ratio is 17.34. In terms of profitability, SNN's ROE is +0.12%, compared to PHG's ROE of +0.08%. Regarding short-term risk, SNN is less volatile compared to PHG. This indicates lower risk in terms of short-term price fluctuations for SNN.Check PHG's competition here
DexCom, Inc. (NASDAQ: DXCM)
SNN vs DXCM Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, DXCM has a market cap of 29.6B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while DXCM trades at $79.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas DXCM's P/E ratio is 31.14. In terms of profitability, SNN's ROE is +0.12%, compared to DXCM's ROE of +0.37%. Regarding short-term risk, SNN is less volatile compared to DXCM. This indicates lower risk in terms of short-term price fluctuations for SNN.Check DXCM's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
SNN vs ZBH Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, ZBH has a market cap of 20.1B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while ZBH trades at $105.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas ZBH's P/E ratio is 12.45. In terms of profitability, SNN's ROE is +0.12%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, SNN is less volatile compared to ZBH. This indicates lower risk in terms of short-term price fluctuations for SNN.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
SNN vs ABMD Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas ABMD's P/E ratio is 65.36. In terms of profitability, SNN's ROE is +0.12%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, SNN is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for SNN.Check ABMD's competition here
Glaukos Corporation (NYSE: GKOS)
SNN vs GKOS Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, GKOS has a market cap of 13.3B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while GKOS trades at $224.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas GKOS's P/E ratio is -260.83. In terms of profitability, SNN's ROE is +0.12%, compared to GKOS's ROE of -0.25%. Regarding short-term risk, SNN is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for SNN.Check GKOS's competition here
Penumbra, Inc. (NYSE: PEN)
SNN vs PEN Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, PEN has a market cap of 12.6B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while PEN trades at $319.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas PEN's P/E ratio is 83.37. In terms of profitability, SNN's ROE is +0.12%, compared to PEN's ROE of +0.10%. Regarding short-term risk, SNN is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for SNN.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
SNN vs SWAV Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas SWAV's P/E ratio is 78.76. In terms of profitability, SNN's ROE is +0.12%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, SNN is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for SNN.Check SWAV's competition here
Align Technology, Inc. (NASDAQ: ALGN)
SNN vs ALGN Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, ALGN has a market cap of 11.8B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while ALGN trades at $166.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas ALGN's P/E ratio is 15.14. In terms of profitability, SNN's ROE is +0.12%, compared to ALGN's ROE of +0.12%. Regarding short-term risk, SNN is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for SNN.Check ALGN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
SNN vs BIO Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, BIO has a market cap of 10.2B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while BIO trades at $381.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas BIO's P/E ratio is 41.12. In terms of profitability, SNN's ROE is +0.12%, compared to BIO's ROE of +0.14%. Regarding short-term risk, SNN is less volatile compared to BIO. This indicates lower risk in terms of short-term price fluctuations for SNN.Check BIO's competition here
Insulet Corp. (NASDAQ: PODD)
SNN vs PODD Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, PODD has a market cap of 10.2B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while PODD trades at $146.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas PODD's P/E ratio is 24.96. In terms of profitability, SNN's ROE is +0.12%, compared to PODD's ROE of +0.29%. Regarding short-term risk, SNN is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for SNN.Check PODD's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
SNN vs BIO-B Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, BIO-B has a market cap of 9.9B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while BIO-B trades at $374.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas BIO-B's P/E ratio is -65.97. In terms of profitability, SNN's ROE is +0.12%, compared to BIO-B's ROE of +0.14%. Regarding short-term risk, SNN is less volatile compared to BIO-B. This indicates lower risk in terms of short-term price fluctuations for SNN.Check BIO-B's competition here
Globus Medical, Inc. (NYSE: GMED)
SNN vs GMED Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, GMED has a market cap of 9.5B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while GMED trades at $71.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas GMED's P/E ratio is 16.00. In terms of profitability, SNN's ROE is +0.12%, compared to GMED's ROE of +0.12%. Regarding short-term risk, SNN is less volatile compared to GMED. This indicates lower risk in terms of short-term price fluctuations for SNN.Check GMED's competition here
Masimo Corporation (NASDAQ: MASI)
SNN vs MASI Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas MASI's P/E ratio is 44.43. In terms of profitability, SNN's ROE is +0.12%, compared to MASI's ROE of +0.09%. Regarding short-term risk, SNN is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for SNN.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
SNN vs BRKR Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, BRKR has a market cap of 9.3B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while BRKR trades at $61.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas BRKR's P/E ratio is 30.81. In terms of profitability, SNN's ROE is +0.12%, compared to BRKR's ROE of -0.05%. Regarding short-term risk, SNN is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for SNN.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
SNN vs BRKRP Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, BRKRP has a market cap of 9.3B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while BRKRP trades at $446.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas BRKRP's P/E ratio is 244.34. In terms of profitability, SNN's ROE is +0.12%, compared to BRKRP's ROE of -0.05%. Regarding short-term risk, SNN is less volatile compared to BRKRP. This indicates lower risk in terms of short-term price fluctuations for SNN.Check BRKRP's competition here
Haemonetics Corporation (NYSE: HAE)
SNN vs HAE Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, HAE has a market cap of 5.5B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while HAE trades at $119.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas HAE's P/E ratio is 23.93. In terms of profitability, SNN's ROE is +0.12%, compared to HAE's ROE of +0.12%. Regarding short-term risk, SNN is less volatile compared to HAE. This indicates lower risk in terms of short-term price fluctuations for SNN.Check HAE's competition here
LivaNova PLC (NASDAQ: LIVN)
SNN vs LIVN Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, LIVN has a market cap of 4.9B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while LIVN trades at $89.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas LIVN's P/E ratio is 21.37. In terms of profitability, SNN's ROE is +0.12%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, SNN is less volatile compared to LIVN. This indicates lower risk in terms of short-term price fluctuations for SNN.Check LIVN's competition here
Inari Medical, Inc. (NASDAQ: NARI)
SNN vs NARI Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas NARI's P/E ratio is -59.24. In terms of profitability, SNN's ROE is +0.12%, compared to NARI's ROE of -0.00%. Regarding short-term risk, SNN is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for SNN.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
SNN vs ITGR Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while ITGR trades at $126.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas ITGR's P/E ratio is 19.94. In terms of profitability, SNN's ROE is +0.12%, compared to ITGR's ROE of +0.06%. Regarding short-term risk, SNN is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for SNN.Check ITGR's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
SNN vs TMDX Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, TMDX has a market cap of 3.1B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while TMDX trades at $88.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas TMDX's P/E ratio is 44.77. In terms of profitability, SNN's ROE is +0.12%, compared to TMDX's ROE of +0.28%. Regarding short-term risk, SNN is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for SNN.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
SNN vs AXGN Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, AXGN has a market cap of 3B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while AXGN trades at $50.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas AXGN's P/E ratio is 131.53. In terms of profitability, SNN's ROE is +0.12%, compared to AXGN's ROE of -0.11%. Regarding short-term risk, SNN is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for SNN.Check AXGN's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
SNN vs IRTC Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, IRTC has a market cap of 3B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while IRTC trades at $90.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas IRTC's P/E ratio is -209.53. In terms of profitability, SNN's ROE is +0.12%, compared to IRTC's ROE of -0.23%. Regarding short-term risk, SNN is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for SNN.Check IRTC's competition here
Neogen Corporation (NASDAQ: NEOG)
SNN vs NEOG Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, NEOG has a market cap of 2.6B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while NEOG trades at $11.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas NEOG's P/E ratio is 42.00. In terms of profitability, SNN's ROE is +0.12%, compared to NEOG's ROE of -0.03%. Regarding short-term risk, SNN is less volatile compared to NEOG. This indicates lower risk in terms of short-term price fluctuations for SNN.Check NEOG's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
SNN vs UFPT Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, UFPT has a market cap of 2.3B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while UFPT trades at $303.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas UFPT's P/E ratio is 30.94. In terms of profitability, SNN's ROE is +0.12%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, SNN is less volatile compared to UFPT. This indicates lower risk in terms of short-term price fluctuations for SNN.Check UFPT's competition here
NuVasive, Inc. (NASDAQ: NUVA)
SNN vs NUVA Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas NUVA's P/E ratio is 75.00. In terms of profitability, SNN's ROE is +0.12%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, SNN is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for SNN.Check NUVA's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
SNN vs ESTA Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, ESTA has a market cap of 2B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while ESTA trades at $67.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas ESTA's P/E ratio is -53.24. In terms of profitability, SNN's ROE is +0.12%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, SNN is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for SNN.Check ESTA's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
SNN vs INSP Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, INSP has a market cap of 1.9B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while INSP trades at $63.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas INSP's P/E ratio is 28.18. In terms of profitability, SNN's ROE is +0.12%, compared to INSP's ROE of +0.12%. Regarding short-term risk, SNN is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for SNN.Check INSP's competition here
Butterfly Network, Inc. (NYSE: BFLY)
SNN vs BFLY Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, BFLY has a market cap of 1.7B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while BFLY trades at $6.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas BFLY's P/E ratio is -26.52. In terms of profitability, SNN's ROE is +0.12%, compared to BFLY's ROE of -0.28%. Regarding short-term risk, SNN is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for SNN.Check BFLY's competition here
Enovis Corporation (NYSE: ENOV)
SNN vs ENOV Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, ENOV has a market cap of 1.6B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while ENOV trades at $27.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas ENOV's P/E ratio is 7.77. In terms of profitability, SNN's ROE is +0.12%, compared to ENOV's ROE of -0.36%. Regarding short-term risk, SNN is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for SNN.Check ENOV's competition here
Novocure Ltd (NASDAQ: NVCR)
SNN vs NVCR Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, NVCR has a market cap of 1.6B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while NVCR trades at $13.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas NVCR's P/E ratio is -12.52. In terms of profitability, SNN's ROE is +0.12%, compared to NVCR's ROE of -0.36%. Regarding short-term risk, SNN is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for SNN.Check NVCR's competition here
CONMED Corporation (NYSE: CNMD)
SNN vs CNMD Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while CNMD trades at $51.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas CNMD's P/E ratio is 11.32. In terms of profitability, SNN's ROE is +0.12%, compared to CNMD's ROE of +0.07%. Regarding short-term risk, SNN is less volatile compared to CNMD. This indicates lower risk in terms of short-term price fluctuations for SNN.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
SNN vs HSKA Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas HSKA's P/E ratio is -62.49. In terms of profitability, SNN's ROE is +0.12%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, SNN is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for SNN.Check HSKA's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
SNN vs LMRI Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, LMRI has a market cap of 1.3B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while LMRI trades at $13.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas LMRI's P/E ratio is -26.07. In terms of profitability, SNN's ROE is +0.12%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, SNN is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for SNN.Check LMRI's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
SNN vs TNDM Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, TNDM has a market cap of 1.2B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while TNDM trades at $16.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas TNDM's P/E ratio is -18.18. In terms of profitability, SNN's ROE is +0.12%, compared to TNDM's ROE of -0.36%. Regarding short-term risk, SNN is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for SNN.Check TNDM's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
SNN vs PRCT Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while PRCT trades at $20.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas PRCT's P/E ratio is -10.62. In terms of profitability, SNN's ROE is +0.12%, compared to PRCT's ROE of -0.33%. Regarding short-term risk, SNN is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for SNN.Check PRCT's competition here
Avanos Medical, Inc. (NYSE: AVNS)
SNN vs AVNS Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas AVNS's P/E ratio is 27.77. In terms of profitability, SNN's ROE is +0.12%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, SNN is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for SNN.Check AVNS's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
SNN vs ATEC Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, ATEC has a market cap of 1.2B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while ATEC trades at $7.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas ATEC's P/E ratio is -13.21. In terms of profitability, SNN's ROE is +0.12%, compared to ATEC's ROE of -5.47%. Regarding short-term risk, SNN is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for SNN.Check ATEC's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
SNN vs SILK Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas SILK's P/E ratio is -18.96. In terms of profitability, SNN's ROE is +0.12%, compared to SILK's ROE of -0.35%. Regarding short-term risk, SNN is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for SNN.Check SILK's competition here
Paragon 28, Inc. (NYSE: FNA)
SNN vs FNA Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas FNA's P/E ratio is -19.83. In terms of profitability, SNN's ROE is +0.12%, compared to FNA's ROE of -0.35%. Regarding short-term risk, SNN is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for SNN.Check FNA's competition here
IRadimed Corporation (NASDAQ: IRMD)
SNN vs IRMD Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while IRMD trades at $86.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas IRMD's P/E ratio is 43.16. In terms of profitability, SNN's ROE is +0.12%, compared to IRMD's ROE of +0.24%. Regarding short-term risk, SNN is less volatile compared to IRMD. This indicates lower risk in terms of short-term price fluctuations for SNN.Check IRMD's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
SNN vs SIBN Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, SIBN has a market cap of 1.1B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while SIBN trades at $24.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas SIBN's P/E ratio is -71.29. In terms of profitability, SNN's ROE is +0.12%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, SNN is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for SNN.Check SIBN's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
SNN vs IART Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, IART has a market cap of 1B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while IART trades at $13.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas IART's P/E ratio is 5.69. In terms of profitability, SNN's ROE is +0.12%, compared to IART's ROE of +0.01%. Regarding short-term risk, SNN is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for SNN.Check IART's competition here
CeriBell, Inc. (NASDAQ: CBLL)
SNN vs CBLL Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, CBLL has a market cap of 1B. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while CBLL trades at $26.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas CBLL's P/E ratio is -15.12. In terms of profitability, SNN's ROE is +0.12%, compared to CBLL's ROE of -0.55%. Regarding short-term risk, SNN is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for SNN.Check CBLL's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
SNN vs AHCO Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, AHCO has a market cap of 998.7M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while AHCO trades at $7.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas AHCO's P/E ratio is 14.95. In terms of profitability, SNN's ROE is +0.12%, compared to AHCO's ROE of -0.29%. Regarding short-term risk, SNN is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for SNN.Check AHCO's competition here
Artivion, Inc. (NYSE: AORT)
SNN vs AORT Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, AORT has a market cap of 985.1M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while AORT trades at $20.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas AORT's P/E ratio is 33.67. In terms of profitability, SNN's ROE is +0.12%, compared to AORT's ROE of -0.04%. Regarding short-term risk, SNN is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for SNN.Check AORT's competition here
Picard Medical, Inc. (AMEX: PMI)
SNN vs PMI Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, PMI has a market cap of 877.7M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while PMI trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas PMI's P/E ratio is -7.12. In terms of profitability, SNN's ROE is +0.12%, compared to PMI's ROE of -9.31%. Regarding short-term risk, SNN is less volatile compared to PMI. This indicates lower risk in terms of short-term price fluctuations for SNN.Check PMI's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
SNN vs CSII Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, CSII has a market cap of 844M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas CSII's P/E ratio is -20.83. In terms of profitability, SNN's ROE is +0.12%, compared to CSII's ROE of -0.14%. Regarding short-term risk, SNN is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for SNN.Check CSII's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
SNN vs KIDS Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, KIDS has a market cap of 829.5M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while KIDS trades at $31.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas KIDS's P/E ratio is -23.71. In terms of profitability, SNN's ROE is +0.12%, compared to KIDS's ROE of -0.10%. Regarding short-term risk, SNN is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for SNN.Check KIDS's competition here
Varex Imaging Corporation (NASDAQ: VREX)
SNN vs VREX Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, VREX has a market cap of 783.4M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while VREX trades at $18.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas VREX's P/E ratio is 19.42. In terms of profitability, SNN's ROE is +0.12%, compared to VREX's ROE of +0.05%. Regarding short-term risk, SNN is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for SNN.Check VREX's competition here
InMode Ltd. (NASDAQ: INMD)
SNN vs INMD Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, INMD has a market cap of 767.6M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while INMD trades at $13.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas INMD's P/E ratio is 9.26. In terms of profitability, SNN's ROE is +0.12%, compared to INMD's ROE of +0.12%. Regarding short-term risk, SNN is less volatile compared to INMD. This indicates lower risk in terms of short-term price fluctuations for SNN.Check INMD's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
SNN vs CTKB Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, CTKB has a market cap of 760.4M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while CTKB trades at $5.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas CTKB's P/E ratio is -30.99. In terms of profitability, SNN's ROE is +0.12%, compared to CTKB's ROE of -0.25%. Regarding short-term risk, SNN is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for SNN.Check CTKB's competition here
Bioventus Inc. (NASDAQ: BVS)
SNN vs BVS Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, BVS has a market cap of 725.1M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while BVS trades at $10.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas BVS's P/E ratio is 13.93. In terms of profitability, SNN's ROE is +0.12%, compared to BVS's ROE of +0.27%. Regarding short-term risk, SNN is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for SNN.Check BVS's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
SNN vs BBNX Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, BBNX has a market cap of 706.8M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while BBNX trades at $15.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas BBNX's P/E ratio is -8.54. In terms of profitability, SNN's ROE is +0.12%, compared to BBNX's ROE of -0.27%. Regarding short-term risk, SNN is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for SNN.Check BBNX's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
SNN vs PACB Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, PACB has a market cap of 700.9M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while PACB trades at $2.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas PACB's P/E ratio is -5.50. In terms of profitability, SNN's ROE is +0.12%, compared to PACB's ROE of +6.04%. Regarding short-term risk, SNN is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for SNN.Check PACB's competition here
Surmodics, Inc. (NASDAQ: SRDX)
SNN vs SRDX Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas SRDX's P/E ratio is -34.66. In terms of profitability, SNN's ROE is +0.12%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, SNN is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for SNN.Check SRDX's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
SNN vs TCMD Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, TCMD has a market cap of 583.1M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while TCMD trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas TCMD's P/E ratio is 24.10. In terms of profitability, SNN's ROE is +0.12%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, SNN is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for SNN.Check TCMD's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
SNN vs APEN Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas APEN's P/E ratio is -9.43. In terms of profitability, SNN's ROE is +0.12%, compared to APEN's ROE of -0.85%. Regarding short-term risk, SNN is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for SNN.Check APEN's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
SNN vs SGHT Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, SGHT has a market cap of 556.4M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while SGHT trades at $10.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas SGHT's P/E ratio is -18.04. In terms of profitability, SNN's ROE is +0.12%, compared to SGHT's ROE of -0.52%. Regarding short-term risk, SNN is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for SNN.Check SGHT's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
SNN vs AVR Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, AVR has a market cap of 554.1M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while AVR trades at $5.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas AVR's P/E ratio is -2.93. In terms of profitability, SNN's ROE is +0.12%, compared to AVR's ROE of -0.78%. Regarding short-term risk, SNN is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for SNN.Check AVR's competition here
ZimVie Inc. (NASDAQ: ZIMV)
SNN vs ZIMV Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, SNN's ROE is +0.12%, compared to ZIMV's ROE of -0.07%. Regarding short-term risk, SNN is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for SNN.Check ZIMV's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
SNN vs DCTH Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, DCTH has a market cap of 518.4M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while DCTH trades at $14.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas DCTH's P/E ratio is 1494.00. In terms of profitability, SNN's ROE is +0.12%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, SNN is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for SNN.Check DCTH's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
SNN vs SENS Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, SENS has a market cap of 453.7M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while SENS trades at $8.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas SENS's P/E ratio is -3.85. In terms of profitability, SNN's ROE is +0.12%, compared to SENS's ROE of -1.66%. Regarding short-term risk, SNN is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for SNN.Check SENS's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
SNN vs SSII Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, SSII has a market cap of 430M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while SSII trades at $2.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas SSII's P/E ratio is -35.75. In terms of profitability, SNN's ROE is +0.12%, compared to SSII's ROE of -0.27%. Regarding short-term risk, SNN is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for SNN.Check SSII's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
SNN vs NPCE Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, NPCE has a market cap of 428.4M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while NPCE trades at $12.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas NPCE's P/E ratio is -21.89. In terms of profitability, SNN's ROE is +0.12%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, SNN is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for SNN.Check NPCE's competition here
Avita Medical Inc. (NASDAQ: RCEL)
SNN vs RCEL Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, RCEL has a market cap of 412.4M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while RCEL trades at $16.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas RCEL's P/E ratio is -11.53. In terms of profitability, SNN's ROE is +0.12%, compared to RCEL's ROE of +1.46%. Regarding short-term risk, SNN is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for SNN.Check RCEL's competition here
Cerus Corporation (NASDAQ: CERS)
SNN vs CERS Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, CERS has a market cap of 406.9M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while CERS trades at $2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas CERS's P/E ratio is -66.94. In terms of profitability, SNN's ROE is +0.12%, compared to CERS's ROE of -0.11%. Regarding short-term risk, SNN is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for SNN.Check CERS's competition here
CapsoVision, Inc. (NASDAQ: CV)
SNN vs CV Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, CV has a market cap of 336M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while CV trades at $6.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas CV's P/E ratio is -10.02. In terms of profitability, SNN's ROE is +0.12%, compared to CV's ROE of -1.78%. Regarding short-term risk, SNN is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for SNN.Check CV's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
SNN vs OFIX Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, OFIX has a market cap of 317.9M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while OFIX trades at $7.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas OFIX's P/E ratio is -5.12. In terms of profitability, SNN's ROE is +0.12%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, SNN is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for SNN.Check OFIX's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
SNN vs SMLR Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas SMLR's P/E ratio is 3.92. In terms of profitability, SNN's ROE is +0.12%, compared to SMLR's ROE of +0.20%. Regarding short-term risk, SNN is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for SNN.Check SMLR's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
SNN vs CLPT Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, CLPT has a market cap of 275.5M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while CLPT trades at $8.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas CLPT's P/E ratio is -7.28. In terms of profitability, SNN's ROE is +0.12%, compared to CLPT's ROE of -1.70%. Regarding short-term risk, SNN is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for SNN.Check CLPT's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
SNN vs INFU Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, INFU has a market cap of 273.5M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while INFU trades at $13.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas INFU's P/E ratio is 33.49. In terms of profitability, SNN's ROE is +0.12%, compared to INFU's ROE of +0.16%. Regarding short-term risk, SNN is less volatile compared to INFU. This indicates lower risk in terms of short-term price fluctuations for SNN.Check INFU's competition here
Profound Medical Corp. (NASDAQ: PROF)
SNN vs PROF Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, PROF has a market cap of 263.8M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while PROF trades at $7.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas PROF's P/E ratio is -7.37. In terms of profitability, SNN's ROE is +0.12%, compared to PROF's ROE of -0.28%. Regarding short-term risk, SNN is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for SNN.Check PROF's competition here
Quantum-Si incorporated (NASDAQ: QSI)
SNN vs QSI Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, QSI has a market cap of 263.6M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while QSI trades at $1.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas QSI's P/E ratio is -2.88. In terms of profitability, SNN's ROE is +0.12%, compared to QSI's ROE of -0.45%. Regarding short-term risk, SNN is less volatile compared to QSI. This indicates lower risk in terms of short-term price fluctuations for SNN.Check QSI's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
SNN vs TMCI Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, TMCI has a market cap of 262.7M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while TMCI trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas TMCI's P/E ratio is -4.30. In terms of profitability, SNN's ROE is +0.12%, compared to TMCI's ROE of -0.76%. Regarding short-term risk, SNN is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for SNN.Check TMCI's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
SNN vs MGRM Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas MGRM's P/E ratio is -12.00. In terms of profitability, SNN's ROE is +0.12%, compared to MGRM's ROE of -1.17%. Regarding short-term risk, SNN is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for SNN.Check MGRM's competition here
Nevro Corp. (NYSE: NVRO)
SNN vs NVRO Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas NVRO's P/E ratio is -1.91. In terms of profitability, SNN's ROE is +0.12%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, SNN is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for SNN.Check NVRO's competition here
Electromed, Inc. (AMEX: ELMD)
SNN vs ELMD Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, ELMD has a market cap of 223.4M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while ELMD trades at $27.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas ELMD's P/E ratio is 20.58. In terms of profitability, SNN's ROE is +0.12%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, SNN is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for SNN.Check ELMD's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
SNN vs TLSI Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, TLSI has a market cap of 199.5M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while TLSI trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas TLSI's P/E ratio is -1.93. In terms of profitability, SNN's ROE is +0.12%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, SNN is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for SNN.Check TLSI's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
SNN vs BSGM Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas BSGM's P/E ratio is -5.81. In terms of profitability, SNN's ROE is +0.12%, compared to BSGM's ROE of +6.96%. Regarding short-term risk, SNN is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for SNN.Check BSGM's competition here
RxSight, Inc. (NASDAQ: RXST)
SNN vs RXST Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, RXST has a market cap of 188.6M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while RXST trades at $4.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas RXST's P/E ratio is -4.01. In terms of profitability, SNN's ROE is +0.12%, compared to RXST's ROE of -0.20%. Regarding short-term risk, SNN is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for SNN.Check RXST's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
SNN vs MDGS Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas MDGS's P/E ratio is -0.27. In terms of profitability, SNN's ROE is +0.12%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, SNN is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for SNN.Check MDGS's competition here
Neuronetics, Inc. (NASDAQ: STIM)
SNN vs STIM Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, STIM has a market cap of 163.4M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while STIM trades at $2.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas STIM's P/E ratio is -4.87. In terms of profitability, SNN's ROE is +0.12%, compared to STIM's ROE of -1.28%. Regarding short-term risk, SNN is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for SNN.Check STIM's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
SNN vs QIPT Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas QIPT's P/E ratio is -15.87. In terms of profitability, SNN's ROE is +0.12%, compared to QIPT's ROE of -0.08%. Regarding short-term risk, SNN is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for SNN.Check QIPT's competition here
Inogen, Inc. (NASDAQ: INGN)
SNN vs INGN Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, INGN has a market cap of 160M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while INGN trades at $6.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas INGN's P/E ratio is -6.63. In terms of profitability, SNN's ROE is +0.12%, compared to INGN's ROE of -0.20%. Regarding short-term risk, SNN is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for SNN.Check INGN's competition here
Quanterix Corporation (NASDAQ: QTRX)
SNN vs QTRX Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, QTRX has a market cap of 137.1M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while QTRX trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas QTRX's P/E ratio is -1.14. In terms of profitability, SNN's ROE is +0.12%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, SNN is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for SNN.Check QTRX's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
SNN vs FOCL Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, FOCL has a market cap of 125.9M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while FOCL trades at $3.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas FOCL's P/E ratio is -3.25. In terms of profitability, SNN's ROE is +0.12%, compared to FOCL's ROE of -2.41%. Regarding short-term risk, SNN is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for SNN.Check FOCL's competition here
Owlet, Inc. (NYSE: OWLT)
SNN vs OWLT Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, OWLT has a market cap of 121.6M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while OWLT trades at $4.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas OWLT's P/E ratio is -29.71. In terms of profitability, SNN's ROE is +0.12%, compared to OWLT's ROE of -0.50%. Regarding short-term risk, SNN is less volatile compared to OWLT. This indicates lower risk in terms of short-term price fluctuations for SNN.Check OWLT's competition here
Pulmonx Corporation (NASDAQ: LUNG)
SNN vs LUNG Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, LUNG has a market cap of 109.9M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while LUNG trades at $2.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas LUNG's P/E ratio is -2.53. In terms of profitability, SNN's ROE is +0.12%, compared to LUNG's ROE of -0.98%. Regarding short-term risk, SNN is less volatile compared to LUNG. This indicates lower risk in terms of short-term price fluctuations for SNN.Check LUNG's competition here
iCAD, Inc. (NASDAQ: ICAD)
SNN vs ICAD Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas ICAD's P/E ratio is -20.37. In terms of profitability, SNN's ROE is +0.12%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, SNN is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for SNN.Check ICAD's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
SNN vs HJLI Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas HJLI's P/E ratio is N/A. In terms of profitability, SNN's ROE is +0.12%, compared to HJLI's ROE of -0.70%. Regarding short-term risk, SNN is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for SNN.Check HJLI's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
SNN vs CATX Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, CATX has a market cap of 95.9M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while CATX trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas CATX's P/E ratio is -0.63. In terms of profitability, SNN's ROE is +0.12%, compared to CATX's ROE of -0.42%. Regarding short-term risk, SNN is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for SNN.Check CATX's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
SNN vs ASXC Comparison November 2026
Smith & Nephew plc (NYSE: SNN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNN stands at 13.1B. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, SNN is priced at $31.15 on the NYSE, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNN currently has a P/E ratio of 21.03, whereas ASXC's P/E ratio is -1.12. In terms of profitability, SNN's ROE is +0.12%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, SNN is more volatile compared to ASXC. This indicates higher risk in terms of short-term price fluctuations for SNN.Check ASXC's competition here